{
  "name": "Vertex Pharmaceuticals",
  "slug": "vertex-pharmaceuticals",
  "ticker": "VRTX",
  "fetched_at": "2025-11-08T12:20:23.164738+00:00",
  "news": [
    {
      "title": "Why Vertex Skidded Despite Its Beat-And-Raise Quarter - Investor's Business Daily",
      "link": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPTm9kVjVUVVFCTkJyZlZxUmdoWkFPVGl1UVBvbnRaanNlQXBCRm1RYjYyYlVDWi12NEZLa3FHMDJ5S1ZjLXc5VUxZTjV1ZVliRi14MkxkV0ZQcFdCS09tZ1JqSDlWeG1Qb1R6WUNkU0E1TjF2SGpfc3A1SnR3Q2lWb21OalN0bGNhdkJRYmRtVlh3Y21jT25yMXlSTQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimwFBVV95cUxPTm9kVjVUVVFCTkJyZlZxUmdoWkFPVGl1UVBvbnRaanNlQXBCRm1RYjYyYlVDWi12NEZLa3FHMDJ5S1ZjLXc5VUxZTjV1ZVliRi14MkxkV0ZQcFdCS09tZ1JqSDlWeG1Qb1R6WUNkU0E1TjF2SGpfc3A1SnR3Q2lWb21OalN0bGNhdkJRYmRtVlh3Y21jT25yMXlSTQ?oc=5\" target=\"_blank\">Why Vertex Skidded Despite Its Beat-And-Raise Quarter</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Investor's Business Daily</font>",
      "published": "2025-11-04T21:13:00+00:00",
      "source": "Investor's Business Daily"
    },
    {
      "title": "Earnings call transcript: Vertex Q3 2025 beats forecasts, stock gains - Investing.com",
      "link": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxQcnd5RXM0X3pHNWlOZGNOc0F2NDJOMTJOeEtNLUpoME1sbVJSYVF3Y0FzYV9pdDJvUXZaMW42MjBsVS0xM2xrVE83Ny1VVmhrVTE2b2xBQ3J0QlVsOUlxZWdoS0xXQ3RsT0RTQ1JjY1ptdXA2cFNxY0xoOWllUERPNnV1dGxJc2tvTnVXdTF1RlFNaGdOdlYxQlI0ZHBQbXJ2LXR6QmZoeXEtNDJKelJkcy1XNERRMi1VZ1JGSl9qMkU?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiwAFBVV95cUxQcnd5RXM0X3pHNWlOZGNOc0F2NDJOMTJOeEtNLUpoME1sbVJSYVF3Y0FzYV9pdDJvUXZaMW42MjBsVS0xM2xrVE83Ny1VVmhrVTE2b2xBQ3J0QlVsOUlxZWdoS0xXQ3RsT0RTQ1JjY1ptdXA2cFNxY0xoOWllUERPNnV1dGxJc2tvTnVXdTF1RlFNaGdOdlYxQlI0ZHBQbXJ2LXR6QmZoeXEtNDJKelJkcy1XNERRMi1VZ1JGSl9qMkU?oc=5\" target=\"_blank\">Earnings call transcript: Vertex Q3 2025 beats forecasts, stock gains</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Investing.com</font>",
      "published": "2025-11-03T23:40:36+00:00",
      "source": "Investing.com"
    },
    {
      "title": "Vertex touts Journavx launch metrics after novel pain med came up just short of expectations in Q3 - Fierce Pharma",
      "link": "https://news.google.com/rss/articles/CBMingFBVV95cUxOZmI4RmlQSm1jV3ZsMlg2UzAtVDQyekVjMXhEcnhpVG9IREstS2VSVjJtN2Rtb2JfY1pEYTJtcnkta2VWSHJCTzBZazJGM1ZvbUpUNERVRFRGTVdxZmY1ZUdZZWFGVTdjNURUQWpiblQ4U3NsYUN0Vm8tZXE4WnVsRWRadTY2b2xWelg4bFQzcUVGc1A4cEktbGZvWVFwQQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMingFBVV95cUxOZmI4RmlQSm1jV3ZsMlg2UzAtVDQyekVjMXhEcnhpVG9IREstS2VSVjJtN2Rtb2JfY1pEYTJtcnkta2VWSHJCTzBZazJGM1ZvbUpUNERVRFRGTVdxZmY1ZUdZZWFGVTdjNURUQWpiblQ4U3NsYUN0Vm8tZXE4WnVsRWRadTY2b2xWelg4bFQzcUVGc1A4cEktbGZvWVFwQQ?oc=5\" target=\"_blank\">Vertex touts Journavx launch metrics after novel pain med came up just short of expectations in Q3</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Pharma</font>",
      "published": "2025-11-04T13:40:00+00:00",
      "source": "Fierce Pharma"
    },
    {
      "title": "Vertex Pharmaceuticals (VRTX) Returns to Profitability, Challenging Bearish Narratives on Earnings Quality - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMimwFBVV95cUxNcGEzNTA5d1hsdWdlMU1kX2VmenppMERSXzZGSnh2SEF1bEcycHRBX2UtRkJkM1l0VGotdzhYWE04My16NVh1MUdKLUVPN0x0aEdfMDVjV0JTZ3FDRGNvVUVTMk5LWUdrWFdLcEFaLTlWWi1QUm9BV2k5akk2ZWJ1R25ZNlk2YUZZYW9BcTNWc1hYWmwxcHZhd2FBRQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimwFBVV95cUxNcGEzNTA5d1hsdWdlMU1kX2VmenppMERSXzZGSnh2SEF1bEcycHRBX2UtRkJkM1l0VGotdzhYWE04My16NVh1MUdKLUVPN0x0aEdfMDVjV0JTZ3FDRGNvVUVTMk5LWUdrWFdLcEFaLTlWWi1QUm9BV2k5akk2ZWJ1R25ZNlk2YUZZYW9BcTNWc1hYWmwxcHZhd2FBRQ?oc=5\" target=\"_blank\">Vertex Pharmaceuticals (VRTX) Returns to Profitability, Challenging Bearish Narratives on Earnings Quality</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-11-05T02:11:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Vertex Reports Third Quarter 2025 Financial Results - Business Wire",
      "link": "https://news.google.com/rss/articles/CBMirAFBVV95cUxOTUlONnpTcmxzTFV3TmFlS2tMNEw3bHA0b05fVTlqOFVsNEZaZmJCNzBzNlNWTXBteTJzVUR3TnlSbEdzM25CN3VmdEJnWGdkMjQxdDdEM3lmcFYtNzU5TVh5YTNqZlBOREpLZ1pJV3NoeF9OaTYwSVkydF80SDdHV3hVYnYwQ0ZIeGVub2tpM1NEa2x6YzdIYWIxb1J5RThoTnIxVnhjTnlrZzUx?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMirAFBVV95cUxOTUlONnpTcmxzTFV3TmFlS2tMNEw3bHA0b05fVTlqOFVsNEZaZmJCNzBzNlNWTXBteTJzVUR3TnlSbEdzM25CN3VmdEJnWGdkMjQxdDdEM3lmcFYtNzU5TVh5YTNqZlBOREpLZ1pJV3NoeF9OaTYwSVkydF80SDdHV3hVYnYwQ0ZIeGVub2tpM1NEa2x6YzdIYWIxb1J5RThoTnIxVnhjTnlrZzUx?oc=5\" target=\"_blank\">Vertex Reports Third Quarter 2025 Financial Results</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Business Wire</font>",
      "published": "2025-11-03T21:02:00+00:00",
      "source": "Business Wire"
    },
    {
      "title": "Vertex Pharmaceuticals Stock is Down 4% Despite Strong Q3 Results - TIKR.com",
      "link": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNWmctaU5ocDNJQkhYeWU1TE9id3plcjdPcE1jR0NYZ2hFMVp6VXJtbzRSMEVRdGo3Z1VYaElRVzlJQ2JOV2F6OFJORlJudEJQMVhzMDExMUZ4Nnc2dlNIaWhjbVJPa2tCVlZzOGVRcmUyVDhfWi1kM2liNTlINmhlN2lRUHZKSEhXWWdCakVkQ0Vhb2l6SElFdzFfdHFJcF9qUy1KaQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMipAFBVV95cUxNWmctaU5ocDNJQkhYeWU1TE9id3plcjdPcE1jR0NYZ2hFMVp6VXJtbzRSMEVRdGo3Z1VYaElRVzlJQ2JOV2F6OFJORlJudEJQMVhzMDExMUZ4Nnc2dlNIaWhjbVJPa2tCVlZzOGVRcmUyVDhfWi1kM2liNTlINmhlN2lRUHZKSEhXWWdCakVkQ0Vhb2l6SElFdzFfdHFJcF9qUy1KaQ?oc=5\" target=\"_blank\">Vertex Pharmaceuticals Stock is Down 4% Despite Strong Q3 Results</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TIKR.com</font>",
      "published": "2025-11-04T10:55:06+00:00",
      "source": "TIKR.com"
    },
    {
      "title": "Vertex Pharmaceuticals: JOURNAVX Prescription Demand And Povetacicept Developments Warrant \"Strong Buy\" - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxOcHp4RTRLVnBPUVVnZkFFY2ZsdzhETENteE5wZ0xjZDZyR1J4WEZycXBIWUozZ284VGpEWFU0OUdjQmFNZGVjSW5mVzZlY3kzM2pTWkZWZ3plckNDUE5VZHMxX0tvTzc0cHp0OFdpNENmT3Z4YjFxc1VMWTNta05uVXhhSjhBX09JU0lKRlZCVmpTcVI4RnVBeXROWE1hbXhPQm94RVRzdlVoVDNFSmUyUkdFX0hiSVdSbWwzVFdzd051Tl85ZjlUMHJSSUFKZUdHajRvN21VVU8?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi2AFBVV95cUxOcHp4RTRLVnBPUVVnZkFFY2ZsdzhETENteE5wZ0xjZDZyR1J4WEZycXBIWUozZ284VGpEWFU0OUdjQmFNZGVjSW5mVzZlY3kzM2pTWkZWZ3plckNDUE5VZHMxX0tvTzc0cHp0OFdpNENmT3Z4YjFxc1VMWTNta05uVXhhSjhBX09JU0lKRlZCVmpTcVI4RnVBeXROWE1hbXhPQm94RVRzdlVoVDNFSmUyUkdFX0hiSVdSbWwzVFdzd051Tl85ZjlUMHJSSUFKZUdHajRvN21VVU8?oc=5\" target=\"_blank\">Vertex Pharmaceuticals: JOURNAVX Prescription Demand And Povetacicept Developments Warrant \"Strong Buy\"</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-11-04T22:23:35+00:00",
      "source": "Seeking Alpha"
    },
    {
      "title": "Agree To Buy Vertex Pharmaceuticals At $290, Earn 6.5% Using Options - Nasdaq",
      "link": "https://news.google.com/rss/articles/CBMilAFBVV95cUxOeWZkd2pHYTZpQWZ6RU0weDQyOU1NZWlNUHNGbmNkMkF1aENMeTE3NWVIdlJ2SmdkV2JaanczZDQ4RU9xRDQwXzhESkVQcFUxZzRWeC1FaVVJRlV4Sk9SQlhRWmVRWkV3ZEUzUGtYMkdjaUhtOGhFQXdCRUViakRuOVJLR2hVbmNILXBINWhJSm51OVQ4?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMilAFBVV95cUxOeWZkd2pHYTZpQWZ6RU0weDQyOU1NZWlNUHNGbmNkMkF1aENMeTE3NWVIdlJ2SmdkV2JaanczZDQ4RU9xRDQwXzhESkVQcFUxZzRWeC1FaVVJRlV4Sk9SQlhRWmVRWkV3ZEUzUGtYMkdjaUhtOGhFQXdCRUViakRuOVJLR2hVbmNILXBINWhJSm51OVQ4?oc=5\" target=\"_blank\">Agree To Buy Vertex Pharmaceuticals At $290, Earn 6.5% Using Options</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Nasdaq</font>",
      "published": "2025-11-06T16:39:00+00:00",
      "source": "Nasdaq"
    }
  ],
  "product_launches": [
    {
      "title": "Vertex Pharmaceuticals Stock is Down 4% Despite Strong Q3 Results - TIKR.com",
      "link": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNWmctaU5ocDNJQkhYeWU1TE9id3plcjdPcE1jR0NYZ2hFMVp6VXJtbzRSMEVRdGo3Z1VYaElRVzlJQ2JOV2F6OFJORlJudEJQMVhzMDExMUZ4Nnc2dlNIaWhjbVJPa2tCVlZzOGVRcmUyVDhfWi1kM2liNTlINmhlN2lRUHZKSEhXWWdCakVkQ0Vhb2l6SElFdzFfdHFJcF9qUy1KaQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMipAFBVV95cUxNWmctaU5ocDNJQkhYeWU1TE9id3plcjdPcE1jR0NYZ2hFMVp6VXJtbzRSMEVRdGo3Z1VYaElRVzlJQ2JOV2F6OFJORlJudEJQMVhzMDExMUZ4Nnc2dlNIaWhjbVJPa2tCVlZzOGVRcmUyVDhfWi1kM2liNTlINmhlN2lRUHZKSEhXWWdCakVkQ0Vhb2l6SElFdzFfdHFJcF9qUy1KaQ?oc=5\" target=\"_blank\">Vertex Pharmaceuticals Stock is Down 4% Despite Strong Q3 Results</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TIKR.com</font>",
      "published": "2025-11-04T10:55:06+00:00",
      "source": "TIKR.com"
    },
    {
      "title": "Earnings call transcript: Vertex Q3 2025 beats forecasts, stock gains - Investing.com",
      "link": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxQcnd5RXM0X3pHNWlOZGNOc0F2NDJOMTJOeEtNLUpoME1sbVJSYVF3Y0FzYV9pdDJvUXZaMW42MjBsVS0xM2xrVE83Ny1VVmhrVTE2b2xBQ3J0QlVsOUlxZWdoS0xXQ3RsT0RTQ1JjY1ptdXA2cFNxY0xoOWllUERPNnV1dGxJc2tvTnVXdTF1RlFNaGdOdlYxQlI0ZHBQbXJ2LXR6QmZoeXEtNDJKelJkcy1XNERRMi1VZ1JGSl9qMkU?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiwAFBVV95cUxQcnd5RXM0X3pHNWlOZGNOc0F2NDJOMTJOeEtNLUpoME1sbVJSYVF3Y0FzYV9pdDJvUXZaMW42MjBsVS0xM2xrVE83Ny1VVmhrVTE2b2xBQ3J0QlVsOUlxZWdoS0xXQ3RsT0RTQ1JjY1ptdXA2cFNxY0xoOWllUERPNnV1dGxJc2tvTnVXdTF1RlFNaGdOdlYxQlI0ZHBQbXJ2LXR6QmZoeXEtNDJKelJkcy1XNERRMi1VZ1JGSl9qMkU?oc=5\" target=\"_blank\">Earnings call transcript: Vertex Q3 2025 beats forecasts, stock gains</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Investing.com</font>",
      "published": "2025-11-03T23:40:36+00:00",
      "source": "Investing.com"
    },
    {
      "title": "Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX) - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5\" target=\"_blank\">Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-08-22T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "VRTX Q3 Deep Dive: New Product Launches and Pipeline Progress Shape Outlook - The Globe and Mail",
      "link": "https://news.google.com/rss/articles/CBMi8gFBVV95cUxPNHdyRV85OXJ0VDQxRkYtTUN2NEtERzVJZ0pzRVBQYVNObWV6ZFpScjFJQnVSeWFhMVdjT0FUM0tSNUJjMHY4WndXZV9JaGZjbnpzdGlRYV91MGNYSkZtbkJWV0xVZlFZbUJMazlmMl9ETV8yVEdnTEI0SURUeER4M1doWVdBWW1NS3FlUmF6alVyaHNvYUlRZXlQNXhQS3p2ZThHS1dDNVVBRXAtYWhWZGVVeDg1WFdkQzFVZHpvanRtc1JXajFQNEhJb2FkVEVRZXB2QnFKM3J3dzMteFNUSDRKUTVNSy1pMFl5WXdMTDd3Zw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi8gFBVV95cUxPNHdyRV85OXJ0VDQxRkYtTUN2NEtERzVJZ0pzRVBQYVNObWV6ZFpScjFJQnVSeWFhMVdjT0FUM0tSNUJjMHY4WndXZV9JaGZjbnpzdGlRYV91MGNYSkZtbkJWV0xVZlFZbUJMazlmMl9ETV8yVEdnTEI0SURUeER4M1doWVdBWW1NS3FlUmF6alVyaHNvYUlRZXlQNXhQS3p2ZThHS1dDNVVBRXAtYWhWZGVVeDg1WFdkQzFVZHpvanRtc1JXajFQNEhJb2FkVEVRZXB2QnFKM3J3dzMteFNUSDRKUTVNSy1pMFl5WXdMTDd3Zw?oc=5\" target=\"_blank\">VRTX Q3 Deep Dive: New Product Launches and Pipeline Progress Shape Outlook</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Globe and Mail</font>",
      "published": "2025-11-04T22:05:14+00:00",
      "source": "The Globe and Mail"
    },
    {
      "title": "Vertex Pharmaceuticals Reports Strong Q3 2025 Results - TipRanks",
      "link": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNMFM4M1o1WTM2UW5zNG1xX0NYMm9vZUZXN3ZpRUZTb21mSmVZWXZaQzdKYVE2Znc3WWxzck5YcVlRWklKeFV3TjdZTXB1bzBtSHJPeWR2dVlwcmZCN2o0MVFHRXR6bHZZSkFDMkFVN1hObWxxSUl5S3cySG9NSEgyUVBybkttaWRiRUZKYWtXNGpGVnQzRjkyTW5Wd0EwalRGdzRRWF9GeFc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNMFM4M1o1WTM2UW5zNG1xX0NYMm9vZUZXN3ZpRUZTb21mSmVZWXZaQzdKYVE2Znc3WWxzck5YcVlRWklKeFV3TjdZTXB1bzBtSHJPeWR2dVlwcmZCN2o0MVFHRXR6bHZZSkFDMkFVN1hObWxxSUl5S3cySG9NSEgyUVBybkttaWRiRUZKYWtXNGpGVnQzRjkyTW5Wd0EwalRGdzRRWF9GeFc?oc=5\" target=\"_blank\">Vertex Pharmaceuticals Reports Strong Q3 2025 Results</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TipRanks</font>",
      "published": "2025-11-04T03:56:57+00:00",
      "source": "TipRanks"
    }
  ],
  "stock": {
    "ticker": "VRTX",
    "currency": "USD",
    "latest": {
      "date": "2025-11-07",
      "close": 409.4700012207031
    },
    "history": [
      {
        "date": "2025-10-30",
        "close": 419.8900146484375
      },
      {
        "date": "2025-10-31",
        "close": 425.57000732421875
      },
      {
        "date": "2025-11-03",
        "close": 426.0
      },
      {
        "date": "2025-11-04",
        "close": 421.6700134277344
      },
      {
        "date": "2025-11-05",
        "close": 417.0
      },
      {
        "date": "2025-11-06",
        "close": 416.25
      },
      {
        "date": "2025-11-07",
        "close": 409.4700012207031
      }
    ],
    "name": "Vertex Pharmaceuticals Incorpor"
  }
}